Tricks and Tips
Showing posts with label INSPIRATION. Show all posts
Showing posts with label INSPIRATION. Show all posts

Friday, October 9, 2020

Clinical Pharmacy In India: Insights in an International Magazine

Dear Readers, Thank you for blogging with us. 
I'm glad to share my interview published in an International Magazine "Leckarnicke Listy" in March 2018. 
Thank you #Dr. Peter Krajcovic, PhD for the interview.

Disclaimer: This interview was originally conducted in a foreign language during my visit to a few European countries and it is further translated to the English version, hence English grammatical errors and vocabulary can be exempted. 





Sunday, October 6, 2019

Dr. Deepak Kumar Bandari, PharmD : Short Profile

Thank you for visiting my blog...!!!
Here you can check out my short profile 

Dr. Deepak Kumar Bandari, PharmD, (PhD) (Europe)
Research Scientist, ICMR-NICPR, Noida.

Current Position: National
1) Project Research Scientist - Indian Council of Medical Research (ICMR) - National Institute of Cancer Prevention and Research (NICPR), Noida and Delhi. 
Project: AccEEND TB, India.
2) Board of Studies Member - Master’s in Clinical Research and Experimental Medicine, School of Allied and Health Sciences, Malla Reddy University, Hyderabad.
3) Book reviewer - BSP Publications, Pharma Med Press and Kakatiya Publications.

Current Position: International

PhD Researcher and Early Stage Researcher participant
Project: FIP 7 programme of EuroAgeism H2020 project, involving 13 European and Non-European countries.
Early-Stage Researcher (ESR) Participant, Euro Ageism H2020, Faculty of Pharmacy in Hradec Králové, Charles University, Europe.
Thesis: Polypharmacy and comparison of differences in potentially inappropriate prescribing in India, Ethiopia, and European countries.
Projects and Grants handled: 
  • Project: FIP 7 programme of EuroAgeism H2020 project, involving 13 European and Non-European countries.
Grant: European Commission, FIP7 program Euro Ageism H2020-764632-MSCA-ITN supported by the scientific group “Ageing and Changes in the Therapeutic Values of Drugs in the Aged”, Charles University, Progress Programme Q42, SVV program 260 417.
Total Finance - 232 422,48 EU (Detailed budget - not disclosed)
EU Consortium: Israel, Czech Republic (CZ), UK, Poland, Netherlands, Sweden, Finland, Belgium.
Participating countries: Czech Republic, Serbia, Croatia, Bulgaria, Estonia, Turkey, Spain, Ireland, Belgium, India, Ethiopia.
Collaborating Institutions: Alliance Health and Social Care Alliance Scotland (AL), EMDA – The Alzheimer’s Association Israel (AAI), European Centre for Social Welfare Policy and Research (Euro Centre), National University of Ireland Galway (NUIG), United Nations Economic Commission for Europe (UNECE) and World Health Organization (WHO).
  • Project No. START/MED/093
Thesis: Rational geriatric pharmacotherapy, medication errors and clinical pharmacy services in long-term care.
Total Finance - 2,299,968 CZK (Personal cost-1,353,600; Mentor remuneration-40,000; Travel costs-361,000; Training costs- 120,000; Costs of non-investment equipment, materials etc. - 80,000; Overhead costs - 345,368)
Grant: Charles University, Research Unit “Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the AgeD”, United Nations Economic Commission for Europe and World Health Organization, University of Zagreb, Croatia, University of Belgrade.

Previous Positions: National
1)Project Technical Support - III (Field Investigator) - Indian Council of Medical Research (ICMR) - National Institute of Nutrition (NIN), Hyderabad, India. 
Project: Strengthening the Monitoring of Tuberculosis Elimination in India - District Level Sentenial Survey (DLSS), India.
2) Associate Consultant (Epidemiology and Outcomes Research) - Bridge Medical Consulting Pvt. Ltd, New Delhi. 
3) Team Leader - Indian Council of Medical Research (ICMR) – National Institute of Nutrition (NIN), Hyderabad, India.
Project: National Sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India.
4) Investigator (Field) - Indian Council of Medical Research (ICMR) – National Institute for Research in Tuberculosis (NIRT), Chennai, India.
Project: National survey for the state-wise prevalence of microbiologically confirmed pulmonary tuberculosis in India.
5) Assistant Professor and Clinical Preceptor: Vaagdevi Institute of Pharmaceutical Sciences, Warangal, India. 
No. of Research Publications: 18
Cumulative Impact Factor: 153
Number of Citations: 3000+
h-index: 14; i-10 index: 15 
Awarded grants: Total 7 (International: 6, National: 1)
Achievements: Total 9 (International: 5, National: 4)
My Interviews in Magazines and Newsletters: 3 (International: 2, National: 1)
Scientific presentations: (International: 11, National: 8)
Book reviews: 9 (International: 2, National: 7)
Guest Lectures: Total 3 (International: 1, National: 2)
Editorial member and reviewer: 8
Certification courses: Total 10 (2 - Stanford University, 8 - National and International Organizations)
Countries affiliated: USA, Italy, Poland, Slovak Republic, The Czech Republic, Germany, Hong Kong and 10 other European countries.


International collaborative research: Early Stage Researcher participant in the FIP 7 programme of EuroAgeism H2020 project under Marie-Curie Innovative Network and EU COST Action IS1402 network aimed at describing main prescribing problems in rational geriatric pharmacotherapy in 13 European and Non- European countries (including India and Ethiopia). 
Collaborating Institutions: Alliance: Health and Social Care Alliance Scotland (AL), EMDA – The Alzheimer’s Association Israel (AAI), European Centre for Social Welfare Policy and Research (EuroCentre), National University of Ireland Galway (NUIG), United Nations Economic Commission for Europe (UNECE) and World Health Organization (WHO).

Remarkable Achievements:
    1. Award and Position: Early Stage Researcher (ESR) participant in the network of FIP7 EuroAgeism H2020 – ITN project, European Commission.
    2. Reviewer: Acknowledged in Davidson’s Principles and Practice of Medicine textbook, 23rd Edition, 2018; Elsevier publishers ISBN: 9780702070280.
    3. Personal interview: “I expect the 8-star Pharmacist Concept of World Health Organization will come true in India in the Future” published in an International Magazine “Lekarnicke Listy”, March 2018, Bratislava, Slovak Republic.
    4. Best reviewer award: Textbook of Hutchison’s Clinical Methods 23rd International Edition by Michael Glynn &William Drake. Saunders Publishers, UK ISBN: 978-0-7020-4091
    5. ERASMUS+ Student Mobility: Internship in various European countries.
A few other Achievements:

1. Award and Interview: Winner of “Ideathon” First Nobel Prize Series in India, Department of Biotechnology, India. Interview entitled “Pharmacist Nobel Prize Series: Science Impacts Lives – The Pride of India”, Indian Pharmaceutical Association – Community Pharmacy Division (IPA - CPD) e-Times 6 (2), March – April 2017.
2. Story of Success (2017): Published by Elsevier, as a part of the budding Medicos National contest.
3. Elsevier Student Ambassador (ESA) and Mentor’ for South Asia from July 2014 to June 2016.
4. Felicitation and award: Special Faculty Achievement Award at Viswambhara Educational Society Silver Jubilee Celebrations, March 2018, Warangal, India.
5. Award: Pharmacy Practice contribution award on World Pharmacist’s Day, 25th September 2017 for the successful delivery of an invited lecture on the Prescriptive role of Clinical Pharmacist in Ambulatory Care at Deccan School of Pharmacy, Hyderabad, India.

Acknowledgement: 
  • I thank Prof. Daniela Fialova, PharmD, PhD, BCCP; Chair of the Horizon 2020 EuroAgeism FIP7 program; Head of the University Centre of Clinical Pharmacy, Faculty of Pharmacy, Charles University; Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Department of Geriatrics and Gerontology,1st Faculty of Medicine, Charles University, Czech Republic.
  • Dr Akshaya Srikanth Bhagavathula, PharmD, PhD; Associate Professor of Epidemiology, Department of Public Health, North Dakota State University, United States of America. 
  • Prof. Yamsani Madhusudan Rao, M.Pharm, PhD; Director, Vaagdevi group of Pharmacy Colleges, Warangal, India for their valuable guidance and support throughout my career.



Tuesday, September 3, 2019

Interact with Nobel Laureates in Germany: For Free | Applications Invited

DEPARTMENT OF SCIENCE & TECHNOLOGY (DST) DST-DFG AWARDS FOR PARTICIPATION IN THE 70th MEETING OF NOBEL LAUREATES & STUDENTS 
Lindau, Germany during 28 June–3 July 2020

Exclusive opportunity for young students and researchers to attend meetings include lectures, panel/ round-table discussions with Nobel Laureates in Germany. Every year applications are invited by Department of Science & Technology, India. Interested Indian Nationals can check out all of the details on the same below:

Each year since 1951, Nobel Prize winners in Chemistry, Physics, Physiology or Medicine have been meeting in Lindau, Germany, to discuss major issues of importance to their fields with students from around the world. The meetings include lectures, panel/ round-table discussions on interdisciplinary topics and informal small- group meetings with the Nobel Prize winners. The DST has been sending a group of students/young researchers to these meetings, since 2001. It intended to send a group of Indian Students /young researchers to the 70th Meeting of Nobel Laureates & Students during 28 June–3 July 2020, which is dedicated to multi-disciplinary subjects viz., Physics, Chemistry and Medicine/Physiology.

Applications are invited from bright and young students and researchers in the above disciplines for availing this award. The lectures and discussions are at a level appropriate for students/researchers in their early research careers. More details of the meeting can be seen at www.lindau-nobel.de

Terms of Award: The selected participants will be provided with International travel-related expenses, local transportation, lodging (twin-sharing basis) and boarding for attending the Meeting. It is mandatory for the selected students to attend the complete full week programme in Germany as well as briefing meeting in Delhi prior to departure to Germany. The Indian team of selected students shall leave for Lindau from Delhi (after briefing meeting) and shall return back to Delhi after the completion of the Nobel laureates meeting and the post Lindau Week. Personal or other visits by candidates to institutes other than the scheduled programme during the above period will not be entertained. The selected candidates will have to make their own arrangements for accommodation and transportation in Delhi for attending the briefing meeting at DST prior to the departure to Germany. The charges for accommodation in Delhi and 2nd AC train tickets from the nearest railway station from their places of residence to New Delhi and back will be reimbursed by DST on submission of the receipts/ train tickets as per the DST norms.

It is mandatory that the selected candidates should submit the reports to DST on the Lindau meetings after completion of the programmes and any information document as and when required by DST within the time frame. No escorts/ accompanying persons will be allowed with the participants and no request for personalized programme during this period would be considered in any case. The applicants would also not be allowed to withdraw the nomination after selection.

Eligibility:

i. Only Indian science students (by citizenship) studying/ working/ affiliated to research Institutes/ universities in India are eligible.
ii. Engineering /Tech. students are not eligible.
iii. Indian students studying and doing post-doc/internship/or staying in Germany / abroad are also not eligible for this award.

For more details check out : Official Website

Wednesday, June 14, 2017

Story of Success - Published by Elsevier

Dear Readers,

Thank you for blogging with us. I'm glad to share my story of success published by Elsevier.Thank you #ElsevierIndia for your kind encouragement. 


Saturday, April 8, 2017

Nobel Prize Series : India

I'm elated to share an article published regarding my achievement in Indian Pharmaceutical Association (IPA) CPD e-times today, Vol 6, Issue 2, page 12. Thanks to Mrs. Manjiri Gharat, for recognising my efforts and encouraging young pharmacists. Credits: Dr. AkshayaSrikanth, the man behind my success, Prof. Y. Madhusudan Rao, the Legend behind my strength.


Sunday, July 3, 2016

Tina Bayuse - First Pharmacist at NASA

After hearing a presentation about drugs in space, Tina Bayuse thought there might be a role for pharmacists in the space programme. She now runs the pharmacy at Johnson Space Center in Houston, Texas.


For a pharmacist who works as a contractor with Wyle for the National Aeronautics and Space Agency (NASA), Tina Bayuse is surprisingly down to earth. “Getting to work with the astronauts!” she exclaims when asked what the most exciting part of her job is. “But, outside of that, being able to witness the change in pharmacy practice. We have a long way to go, but it’s amazing to see where we’ve come in the space programme since I first started in 2000 to where we are today.”

Bayuse was the first pharmacist ever to work for NASA and now heads a team of four in its own pharmacy at Johnson Space Center (JSC) in Houston, so she has certainly seen change during her career. Much of the team’s work now focuses on preparing the ‘med kits’ for astronauts at the International Space Station, of which there are two types: ‘convenience’ and ‘contingency’. The convenience kit contains medicines that one would usually take on a trip, whereas the contingency kit is made up of drugs such as antibiotics and cardiac life support. “We have an entire group of people who are responsible for the design,” Bayuse expains, “but the contents of the kits actually come from the pharmacy here at JSC. We’re responsible for preparing them for flight and then also packing them into the flight kits with the engineers.”


Medicines in space

Sending medicines into space is much like dispensing medicines terrestrially, but with a few additional concerns. “If there is a shortage of a drug, it affects what the astronauts are trained on and what the biomedical engineers understand to be in the med kit,” she emphasises.

Medicines also have to be selected based on volume and mass on board the space station, which can prove problematic with certain formulations, such as soluble powders or drinks. “Most of our veteran fliers understand this, but sometimes we’ll get somebody who’s never flown before or, more importantly, a doctor who has not been on a mission before,” she says. “On the rare occasions that something like that would be requested, we try to take care of those questions prior to preparing the medicines for packing. Because at the time of packing it’s too late.”

Additionally, there are limits on what the environmental systems in orbit can handle — managing alcohol levels in medicines, for example, can be a challenge. Astronauts may need to take medicines while wearing their suits, outside the space station, so this also needs to be taken into account. “We also make sure that we try to advocate a drug tolerance testing for our crews for medicines that they may not take routinely, in case something they take in orbit affects their cognitive abilities or produces unwanted side effects,” she says.

Planning for missions to the space station is fairly routine for Bayuse, but she is currently considering additional challenges that may be introduced when astronauts begin flying to Mars. “We’re not going to have resupply like we do for the station,” she highlights. “In the [United States] we have a rule where, once you take something out of the manufacturer’s packaging, it is only good for one year.” At the moment, this means that items in the convenience kit are repackaged, but those in contingency pack remain in their original packaging. The effect of radiation on medicines outside lower Earth orbit is also unknown.

It is imperative that quality control is enforced, so a triple-check process is in place, with a different pharmacist checking each time. “We haven’t had a mistake that leaves the door because, if it’s going on orbit, it could be national headlines. International headlines,” she emphasises.

Getting into NASA

Bayuse was interested in space flight since she was a child, but knew that she could not be an astronaut for various health reasons. She began working in her local pharmacy and, after a couple of false starts reading physics and biology, started studying pharmacy. “When I was in my first year of pharmacy school, I attended a presentation about the fact that drugs may not work the same in space,” she remembers. “This presentation was after school in a completely different location I had to drive to. I was in a new city, I wasn’t really comfortable with that, but I thought, heck, I’m going to go anyway and see this speaker.”

After the meeting, Bayuse approached the speaker and asked if there was an opportunity to be involved in any way. “She put me in contact with the person who was running the pharmacology lab at the time and, through years of talking back and forth with this person, I was able to create a rotation to come to Houston and look at what it meant to be part of the space programme with pharmacology as a focus.

“I spent a month at Houston, working in the lab, not doing anything in depth but getting a cursory glance at the work they were doing. Then I did a couple of pharmacy-related projects, working on some drug monographs for the space shuttle — the content of the space shuttle med kit.”

Her work intrigued the medical and pharmacological teams at NASA — so much so that they decided to create a pharmacy position at the lab. “That took quite a long time to come to fruition,” Bayuse recalls, “I actually almost gave up on it, I was in the match programme for residencies. But then I got the phone call that they had created the position and they wanted to know if I would apply for it. So here I am.”
Finding a place at the table

Although Bayuse started work in the pharmacology lab, a review of NASA’s medication management revealed that practices were out of date. “The decision was made that they would have an on-site pharmacy with pharmacy staff to manage everything that we do here terrestrially. We opened the pharmacy on 31 March 2003,” she says.

“It’s not like there’s a training programme for this,” she explains. “I had good mentors who were willing to help me understand things. A lot of it is self taught.” She adds that a good understanding of how to read literature — “not my favourite thing” — is important for the role, as are excellent writing and speaking skills.

“My particular position has morphed into educating people outside the healthcare discipline about what pharmacy does and why we should be involved,” says Bayuse. “Most pharmacists are going to be working with other healthcare providers like physicians and nurses on a routine basis, so you all have the same common language. When you step outside that, and you’re working with non-healthcare providers such as engineers and programme managers who bring a different perspective to the table, being able to communicate with people in those disciplines is imperative.”

She is proud of how far pharmacy at NASA has come. “Before we had to beg to be able to sit at the table, or we would find out after [work had already begun] and then have to do some quick work to make [a project] feasible. But now we’re actually being included from the ground floor and that would probably be my greatest professional achievement,” she enthuses.

Despite these advances, Bayuse says she has to continue to champion the role of pharmacy, particularly to those monitoring the bottom line. “Nobody likes metrics!” she notes. “But choose metrics that will help to prove your point, especially to budget people. And then stay on top of it. Pharmacy is more proactive than a lot of medical professions because being reactive in the pharmacy profession is a bad day.”

For example, with regard to the potential advent of commercial space flight, Bayuse explains that initially pharmacy was not included in the conversation. “It’s not because they are trying to leave you out intentionally, it’s just because they haven’t thought about it from that perspective yet,” she says philosophically, adding that the department is now involved in the plans because of her persistence.

However, her patients do appreciate the work she does — one of the astronauts recently called her from the space station to thank her for helping him get ready for his flight. “Actually having your work recognised by a patient — let alone an astronaut on a space station — is something that pharmacists in general don’t see… so having that recognition for all the work that you do accomplish on their behalf is rewarding,” she adds.

Seeking out a role

Bayuse does not yet see a role for an expanded pharmacy team at NASA, but says that the advent of commercial space flight may present new opportunities, for both pharmacy research and practice. “The health of the general public is not going to be as pristine as our astronaut corps so there will be a role for pharmacists in managing those kinds of disease states and the medicines that come along with that,” she explains.

For any pharmacist looking to work in a pioneering area, Bayuse recommends being persistent. “Along with that, if you have an interest in an area, learn as much as you can about it,” she says. “Understand the rules and regulations that go along with that particular area because that’s a big deal. If you’re interested in something outside the box and there are organisations tied to that interest — such as, in my case, the Aerospace Medicine Association — reach out to them and find out when they are having meetings so you can attend.”

Saturday, January 16, 2016

Woman behind every smile of a Cancer Patient : Salute Her

Dear Readers..!!! Thanks for visiting my blog...!!!

Today I would like to introduce you Her Excellency Prof. Dr. Gayatri Palat, MD - "a woman behind every smile of a cancer patient". Indeed its my privilege to be a trainee under the guidance of the team led by her. This team of MNJ institute of Oncology, INCTR, Pallium India and Two Worlds Cancer Collaboration has entirely changed my views and perceptions of Palliative care and approach towards the patient. The handwork, dedication, moral support and ethical approach shown by every member of the team is immense and they have once again proved how a team work can do miracles by bringing smiles in patients even at their end stage of life. 

Palliative Care for Children in a Resource Poor Setting, an Indian initiative
In Her words: 

Today, a child diagnosed with cancer in a developed country has an 80% chance of being cured. Unfortunately, this is not true in India where 75,000 children with recorded cancers each year have a survival rate of less than 20%. Furthermore, of the estimated 2.5 million people in India living with HIV/AIDS, 70,000 are children under the age of 15. Less than 0.4% of needy children have access to palliative care programs designed to address their needs.

Palliative Care for Children in the Mehdi Nawaj Jung (MNJ) Institute of Oncology (MNJIO), Hyderabad 

The MNJ Institute of Oncology is a 300 bed tertiary care hospital in the state of Andhra Pradesh, India (population of 65 million). Every year the hospital sees around 1,000 children with cancer.Most of the children require long, intensive curative treatment. Enormous suffering results from painful procedures, undesirable symptoms and the emotional trauma of facing potentially life threatening illnesses. Many children develop severe anxiety, depression and become withdrawn and non-communicative. Families often travel long distances and stay in the hospital for weeks and when the need for community and family support is greatest, they are totally deprived of it. Very early in our endeavour to cure these children, we realized the dire need for an effective palliative care program for both the children and their families as they confront cancer with all of its physical, psychosocial and spiritual effects. 

MNJIO Pain Relief and Palliative Care Program, a collaboration of the International Network for Cancer Treatment and Research (INCTR) and Pallium India added paediatric palliative care to their service in 2007. The primary goal of the program is zero-tolerance of pain beginning at diagnosis. Since the paediatric program was established, there has been a rapid increase in the number of children treated beginning with 69 patient visits in 2006 and 2,922 in 2010 ( Fig 1). 70% of children suffered from leukaemia and pain was the most common symptom at referral. Other common symptoms included mouth ulcers, constipation, vomiting and tiredness. The total opioid consumption for the year 2010 was 150gms. Every child undergoing interventions such as intrathecal or bone marrow injections received EMLA cream application +/- oral midazolam before the procedure. Other activities included regular weekly support groups, recreational and educational activities, home based care and regular and emergency telephonic consults.

A few successful outcomes of the program have been: 
  • almost all children receiving cancer treatment and their families are also receiving adequate symptom control and psychosocial support during curative treatment along with a smooth transition to end of life care if required, 
  • there has been a significant reduction in the dropout rate during treatment, and 
  • there is good implementation of procedure-related pain relief protocols. 
Scope of the program:

The paediatric pain and palliative care program is the first of its kind for the entire state of Andhra Pradesh. While the program is currently designed to cater only to the needs of children with cancer, we plan to expand it to include all children living with HIV and AIDS and other life threatening illnesses. A fellowship course in paediatric palliative care will start soon to train specialists in the field.